|
Recent Developments |
|
24-AUG-16
Mangalam Drugs & Organics, one of the leading Pharma/API Company has successfully completed the expansion/ modernization work of its Plant on Unit-2 situated at Vapi.
16-APR-15
IPCA Laboratories has sold 0.81% stake in Mangalam Drugs & Organics on Thursday for Rs 3.63 million. It has sold 0.10 million shares at an average price of Rs 33.68 on the NSE.
Future Plans
The company plans to diversify into anti-diabetic and fluoroquino... More.. |
| Business Profile |
Future Plans |
|
|
|
|
One To One
|
|
Recent news
|
|
|
| Brief Financials (in Rs. Mn.) | |
| Period ending (months) | 30-Sep-2016(6) | 31-Mar-2016(12) | 31-Mar-2015(12) | | Net sales | 1434.84 | 2951.60 | 2205.83 | | Other Income | 0.07 | 0.21 | 0.52 | | Total Income | 1434.91 | 2951.81 | 2206.35 | | Cost of goods sold | 659.70 | 2585.45 | 2002.62 | | OPBDIT | 775.21 | 366.36 | 203.73 | | PAT | 109.39 | 160.34 | 61.42 | | Gross Block | - | - | - | | Equity capital | 158.28 | 143.78 | 131.78 | | EPS (Rs.) | - | - | - | | DPS (Rs.) | - | - | - | | BV (Rs.) | - | - | - | | P/E range (x) | - | - | - | | Debt / Equity (x) | - | - | - | | Operating margin (% of OI) | 54.0 | 12.4 | 9.2 | | Net margin (% of OI) | 7.6 | 5.4 | 2.8 |
|
|
Detailed Financials
|
|
|
|
|
